Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16:17–29.

Article  PubMed  Google Scholar 

Carneiro RM, Carneiro BA, Agulnik M, Kopp PA, Giles FJ. Targeted therapies in advanced differentiated thyroid cancer. Cancer Treat Rev. 2015;41:690–8.

Article  CAS  PubMed  Google Scholar 

Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644–60.

Article  CAS  PubMed  Google Scholar 

Crispo F, Notarangelo T, Pietrafesa M, Lettini G, Storto G, Sgambato A, et al. BRAF inhibitors in thyroid cancer: clinical impact, mechanisms of resistance and future perspectives. Cancers. 2019;11:1388.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrari SM, Elia G, Ragusa F, Ruffilli I, La Motta C, Paparo SR, et al. Novel treatments for anaplastic thyroid carcinoma. Gland Surg. 2020;9:S28–S42.

Article  PubMed  PubMed Central  Google Scholar 

Al-Jundi M, Thakur S, Gubbi S, Klubo-Gwiezdzinska J. Novel targeted therapies for metastatic thyroid cancer-a comprehensive review. Cancers. 2020;12:2104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16:201–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem. 2008;104:733–44.

Article  CAS  PubMed  Google Scholar 

Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034.

Article  PubMed  PubMed Central  Google Scholar 

Pacifico F, Leonardi A. Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol. 2010;321:29–35.

Article  CAS  PubMed  Google Scholar 

Shiraiwa K, Matsuse M, Nakazawa Y, Ogi T, Suzuki K, Saenko V, et al. JAK/STAT3 and NF-kappaB signaling pathways regulate cancer stem-cell properties in anaplastic thyroid cancer cells. Thyroid. 2019;29:674–82.

Article  CAS  PubMed  Google Scholar 

Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.

Article  Google Scholar 

Maubach G, Feige MH, Lim MCC, Naumann M. NF-kappaB-inducing kinase in cancer. Biochimica et Biophys Acta Rev Cancer. 2019;1871:40–9.

Article  CAS  Google Scholar 

Birbach A, Bailey ST, Ghosh S, Schmid JA. Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIK. J Cell Sci. 2004;117:3615–24.

Article  CAS  PubMed  Google Scholar 

Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene. 1997;15:1987–94.

Article  CAS  PubMed  Google Scholar 

Pacifico F, Mauro C, Barone C, Crescenzi E, Mellone S, Monaco M, et al. Oncogenic and anti-apoptotic activity of NF-kappa B in human thyroid carcinomas. J Biol Chem. 2004;279:54610–9.

Article  CAS  PubMed  Google Scholar 

Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, et al. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab. 2006;91:4013–21.

Article  CAS  PubMed  Google Scholar 

Pyo JS, Kang G, Kim DH, Chae SW, Park C, Kim K, et al. Activation of nuclear factor-kappaB contributes to growth and aggressiveness of papillary thyroid carcinoma. Pathol, Res Pract. 2013;209:228–32.

Article  CAS  PubMed  Google Scholar 

Starenki D, Namba H, Saenko V, Ohtsuru A, Yamashita S. Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells. J Clin Endocrinol Metab. 2004;89:410–8.

Article  CAS  PubMed  Google Scholar 

Siggers T, Chang AB, Teixeira A, Wong D, Williams KJ, Ahmed B, et al. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappa B family DNA binding. Nat Immunol. 2012;13:95–U123.

Article  CAS  Google Scholar 

Smale ST. Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors. Immunological Rev. 2012;246:193–204.

Article  Google Scholar 

de Oliveira KA, Kaergel E, Heinig M, Fontaine JF, Patone G, Muro EM, et al. A roadmap of constitutive NF-kappaB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. Genome Med. 2016;8:28.

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Wu J, Wang JK. A database and functional annotation of NF-kappa B target genes. Int J Clin Exp Med. 2016;9:7986–95.

CAS  Google Scholar 

Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309–24.

Article  CAS  PubMed  Google Scholar 

Tegowski M, Baldwin A. Noncanonical NF-kappaB in cancer. Biomedicines. 2018;6:66.

Article  PubMed  PubMed Central  Google Scholar 

Bauerle KT, Schweppe RE, Haugen BR. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion. Mol cancer. 2010;9:117.

Article  PubMed  PubMed Central  Google Scholar 

Bauerle KT, Schweppe RE, Lund G, Kotnis G, Deep G, Agarwal R, et al. Nuclear factor kappaB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. J Clin Endocrinol Metab. 2014;99:E1436–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wunderlich A, Arndt T, Fischer M, Roth S, Ramaswamy A, Greene BH, et al. Targeting the proteasome as a promising therapeutic strategy in thyroid cancer. J surgical Oncol. 2012;105:357–64.

Article  CAS  Google Scholar 

Garcia C, Buffet C, El Khattabi L, Rizk-Rabin M, Perlemoine K, Ragazzon B, et al. MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer. Oncotarget. 2019;10:2320–34.

Article  PubMed  PubMed Central  Google Scholar 

Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646–56.

Article  CAS  PubMed  Google Scholar 

Pyo JS, Sohn JH, Kang G, Kim DH, Kim DH. Characteristics of neck level VI lymph nodes in papillary thyroid carcinoma: correlation between nodal characteristics and primary tumor. Endocr Pathol. 2015;26:15–20.

Article  CAS  PubMed  Google Scholar 

Spada S, Tocci A, Di Modugno F, Nistico P. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J Exp Clin cancer Res. 2021;40:102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278:16–27.

Article  CAS  PubMed  Google Scholar 

Gondi CS, Rao JS. Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases. Methods Mol Biol. 2009;487:267–81.

CAS  PubMed  PubMed Central  Google Scholar 

Santiago-Sanchez GS, Pita-Grisanti V, Quinones-Diaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mejia PE. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer. Int J Mol Sci. 2020;21:4365.

Article  PubMed  PubMed Central  Google Scholar 

Sponziello M, Rosignolo F, Celano M, Maggisano V, Pecce V, De Rose RF, et al. Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells. Mol Cell Endocrinol. 2016;431:123–32.

Article  CAS  PubMed  Google Scholar 

Ulisse S, Baldini E, Toller M, Marchioni E, Giacomelli L, De Antoni E, et al. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Eur J cancer. 2006;42:2631–8.

Article  CAS  PubMed  Google Scholar 

Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, et al. Downreg